Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
about
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsCerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatmentThe distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses.HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentAn Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future ResearchPaving the path to HIV neurotherapy: Predicting SIV CNS diseaseHIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.Clinical Trials in Neurovirology: Successes, Challenges, and PitfallsChanges in cerebral metabolism are detected prior to perfusion changes in early HIV-CMC: A coregistered (1)H MRS and SPECT study.Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection.Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsNeurocognitive effects of HIV, hepatitis C, and substance use historySTAT3 and its phosphorylation are involved in HIV-1 Tat-induced transactivation of glial fibrillary acidic proteinMode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological SymptomsGenetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.Genetic variation and HIV-associated neurologic disease.High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis.Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells.Neuropsychiatric manifestations of HIV infection and AIDSSimian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNACerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.HIV-associated neurocognitive disorder.Indinavir population pharmacokinetics in plasma and cerebrospinal fluid. The HIV Neurobehavioral Research Center Group.Neurobehavioural consequences of substance abuse and HIV infection.Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder.Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variables.Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1.Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study.Antiretroviral treatment of central nervous system HIV-1 infection: a review.A machine learning approach for identifying amino acid signatures in the HIV env gene predictive of dementia.Neuropsychiatric Effects of HIV Antiviral Medications.HIV, dementia and antiretroviral drugs: 30 years of an epidemic.Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis.Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.In vitro and animal models of human immunodeficiency virus infection of the central nervous systemHIV-associated neurocognitive disorders: perspective on management strategiesLentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility
P2860
Q24631745-F0FC1765-EBE4-4296-8CC8-82C0A32CF0DEQ24814874-D752C6AE-3A9F-4843-944A-DB7AE86589B1Q25257032-E409E3F4-82C6-4A44-BFD2-EF734205C3BCQ26766448-D26398BB-B3D5-4111-847C-9F28AF9426F5Q26829172-F2EA727A-32E2-442E-B1C0-4D329E541272Q26852969-2F3E8B2E-5542-4108-9299-807128455176Q30234305-DD3D1AB2-6A3D-4981-8940-9A05B3C4DC73Q30250271-76C7206E-AC9F-419B-ABAF-D7F00B8F7FCFQ31651608-DD8FBB2A-983B-42A9-AD95-C54085C8795EQ33181807-9CAF3C7E-A938-4C12-8E68-519C8ED84356Q33311631-9E3AC17D-E14F-4B63-A64E-CD7CCC6906DFQ33614467-C967C69A-9735-4E75-8601-80EE7A1B39CBQ33652957-B489A180-BF00-4894-B3D0-3C3E770F22E7Q33675464-C7480BD1-9492-4D28-8C3E-A00F454EB09DQ33686847-20C949BB-7785-447E-A4B7-43484C0FE586Q33699222-1B7F2C1B-AD3A-4952-A494-DA606DFE1C5EQ33712027-ED47EF83-A45A-47FD-9749-18098217D15AQ33716348-FE2A8463-A70C-4364-9922-67F91715FB2DQ33819189-B0583931-FFEB-416E-80CA-B702C4AD1549Q33825647-3C0847B7-7706-4D90-9093-3E216759224DQ33843510-4E275FD0-E001-4429-B955-18EA343F78BBQ33868874-1993889F-7ACF-4B8E-A777-922CF664946AQ33893665-CBB7A13E-ED64-4CD8-A81A-BD40F45E48DEQ33933507-A78342B4-1EE8-4579-A93B-FFD2C55B2939Q33939729-4AA1698A-733B-4A40-8FD8-11B49FD39B9DQ33980273-2DB87A7A-F2D0-4568-A05A-968C9783EB28Q34098781-382B5BDE-98C3-4724-88B0-9BB822CC3C80Q34103216-E6DFA07B-5E34-4CAD-A974-25F9B2FCEDB5Q34215731-B49A3EBA-ADE2-49D7-863B-589B6C2EDB99Q34309626-FAAB3BEC-CE6A-4B9C-88EE-710DDC9E672EQ34387874-4053177C-2504-4716-A87A-7AF281D11FFAQ34459372-966038E6-4687-49C9-93A3-2113206FCB22Q34482480-AA976907-A579-4942-94A9-9CF69BFC366BQ34537705-38A729AC-D833-4CA5-B35B-2418079D6F42Q34573511-40975A4F-FD66-457F-93D5-FF0C8BE24D7BQ34590964-75CAA4A2-2625-4841-9A14-5657711BFC91Q34615228-B8B478B1-3AEA-4907-A7A5-2DF14D9D4679Q34621972-55951DC6-4166-4E76-B9A9-C156E312D1E3Q34652590-7B385B6D-B61E-4728-88B7-506875258F89Q34755001-0FE66235-957D-428C-B28A-A13DD272C4FB
P2860
Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Relationship between human imm ...... cerebrospinal fluid and brain.
@en
Relationship between human imm ...... cerebrospinal fluid and brain.
@nl
type
label
Relationship between human imm ...... cerebrospinal fluid and brain.
@en
Relationship between human imm ...... cerebrospinal fluid and brain.
@nl
prefLabel
Relationship between human imm ...... cerebrospinal fluid and brain.
@en
Relationship between human imm ...... cerebrospinal fluid and brain.
@nl
P2093
P2860
P921
P356
P1433
P1476
Relationship between human imm ...... cerebrospinal fluid and brain.
@en
P2093
McArthur JC
McClernon DR
Nance-Sproson TE
St Clair M
P2860
P304
P356
10.1002/ANA.410420504
P577
1997-11-01T00:00:00Z